arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 8/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Parkinson's disease: inhaled levodopa (INBRIJA) for off periods

    THERAPY FROM A CRITICAL VIEWPOINT

    Baricitinib (OLUMIANT) against COVID-19

    a-t READERS QUESTIONS AND COMMENTS

    Vascular calcification due to coumarin anticoagulants?

    IN BRIEF

    The new “flu” vaccines for 2022/23

    Insufficient information on the antiemetic therapy during treatment with apomorphine (e.g. APO-GO)

    Icosapent ethyl (VAZKEPA) off market

    Is vitamin D effective against fractures in healthy adults?

    EMA and FDA: identical data differently interpreted

    SIDE EFFECTS

    Myocarditis/pericarditis with the protein-based SARS-CoV-2 vaccine NVX-COV2373 (NUVAXOVID)

    PML with the multiple sclerosis drug ocrelizumab (OCREVUS)
    free

    Biliary tract diseases - increases risk also with DPP-4 inhibitors

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!